Kiniksa Pharmaceuticals International (KNSA) EBIT Margin (2021 - 2026)
Kiniksa Pharmaceuticals International (KNSA) recorded EBIT Margin of 11.16% in Q2 2026, down 1.69 percentage points from 12.86% a year earlier and down 2.50 percentage points from the prior quarter.
Kiniksa Pharmaceuticals International (KNSA) EBIT Margin (2021 - 2026) Analysis & Trends
On a TTM basis, Kiniksa Pharmaceuticals International's EBIT Margin came in at 11.92% as of Jun 30, 2026, up 11.08 percentage points year-over-year; for FY2025, it came in at 11.40%, up 22.17 percentage points from FY2024.
- Annual EBIT Margin has a four-year change of +417.78 percentage points (FY2021 to FY2025).
- Across earlier years, EBIT Margin came in at -10.78% in FY2024 (-1.45 pp), -9.32% in FY2023 (-13.76 pp), 4.44% in FY2022 (+410.82 pp) and -406.38% in FY2021.
- Quarterly EBIT Margin has ranged from -253.55% in Q3 2021 to 46.82% in Q3 2022 over the past five years.
- On a year-over-year basis, EBIT Margin rose in six of the last eight quarters, with an average year-over-year change of +10.61 percentage points.
- Peak year-over-year performance for EBIT Margin in the last five years was a gain of 454.61 percentage points in Q2 2022, against a drop of 63.12 percentage points in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at 13.66% (Q1 2026), 9.78% (Q4 2025) and 13.28% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 28.37% |
| 10 | Kiniksa Pharmaceuticals International | 6.18 Bn | 4.92 Bn | 220.03 Mn | 11.16% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.16% |
| Mar 31, 2026 | 13.66% |
| Dec 31, 2025 | 9.78% |
| Sep 30, 2025 | 13.28% |
| Jun 30, 2025 | 12.86% |
| Mar 31, 2025 | 9.63% |
| Dec 31, 2024 | -15.75% |
| Sep 30, 2024 | -8.61% |
| Jun 30, 2024 | -0.11% |
| Mar 31, 2024 | -20.71% |
| Dec 31, 2023 | 0.10% |
| Sep 30, 2023 | -16.30% |
| Jun 30, 2023 | -4.41% |
| Mar 31, 2023 | -23.16% |
| Dec 31, 2022 | 9.77% |
| Sep 30, 2022 | 46.82% |
| Jun 30, 2022 | -71.81% |
| Mar 31, 2022 | -72.44% |
| Dec 31, 2021 | -192.75% |
| Sep 30, 2021 | -253.55% |
Kiniksa Pharmaceuticals International EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=KNSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "KNSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=KNSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();